Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Smith_&_Nephew
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:focusesOn |
stem cell research
regenerative medicine |
| gptkbp:foundedYear |
1992
|
| gptkbp:founder |
gptkb:Arnold_Caplan
gptkb:James_S._Burns gptkb:Peter_Friedli |
| gptkbp:headquartersLocation |
gptkb:Columbia,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Osiris Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableAchievement |
first company to commercialize stem cell products
|
| gptkbp:notableProduct |
gptkb:Cartiform
gptkb:Grafix gptkb:TruSkin |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:OSIR
|
| gptkbp:website |
https://www.osiris.com/
|
| gptkbp:bfsParent |
gptkb:Smith_&_Nephew
|
| gptkbp:bfsLayer |
7
|